BRIDGEBIO PHARMA INC revenue breakdown overview

BRIDGEBIO PHARMA INC revenue for the last year amounted to 214.35 M EUR, the most of which — 214.35 M EUR — came from its highest performing source at the moment, Transformative Medicines, the year earlier bringing 8.43 M EUR. The greatest contribution to the revenue figure was made by EMEA — last year it brought BRIDGEBIO PHARMA INC 127.54 M EUR.